TABLE 1 MAL Protein Expression in Lymphocyte Subsets in Normal Peripheral Blood, Tonsil, and Spleen Samples

From: MAL Expression in Lymphoid Cells: Further Evidence for MAL as a Distinct Molecular Marker of Primary Mediastinal Large B-Cell Lymphomas

Lymphocyte Subset

Sample

B Cellsa(%)

MAL+ Cells Among B Cells (%)

CD4 TaCells (%)

MAL+ Cells among CD4 T Cells (%)

CD8 TaCells (%)

MAL+ Cells among CD8 T Cells (%)

Peripheral blood lymphocytes

1

8

0

56

65

19

28

 

2

22

0.6

35

85

31

39

 

3

9

0

48

90

32

26

 

4

11

0.3

40

77

28

22

Tonsil

5

75

1.5

16

31

3.7

27

 

6

70

2

22

76

9

50

Spleen

7

45

0.6

19

70

38

5

 

8

61

0.7

16

90

18

27

  1. The percentages represent the proportion of positive elements in the lymphocyte gate. Results were obtained by two multiple-labelings, MAL/CD19, and MAL/CD3/CD4 combinations under permeabilization conditions (0.1% saponin).
  2. aB cells were defined as CD19+ cells, CD4 T cells as CD4+CD3+ cells, and CD8 T cells as CD4−CD3+ cells.
Back to article page